Adhikary L, Chow F, Nikolic-Paterson D J, Stambe C, Dowling J, Atkins R C, Tesch G H
Department of Nephrology, Monash Medical Centre, 246 Clayton Road, Clayton, Victoria 3168, Australia.
Monash University Department of Medicine, Monash Medical Centre, Clayton, Victoria, Australia.
Diabetologia. 2004 Jul;47(7):1210-1222. doi: 10.1007/s00125-004-1437-0. Epub 2004 Jul 1.
AIMS/HYPOTHESIS: Inflammation and fibrosis are pathological mechanisms that are partially regulated by cell signalling through the p38 mitogen-activated protein kinase (MAPK) pathway. Elements of the diabetic milieu such as high glucose and advanced glycation end-products induce activation of this pathway in renal cells. Therefore, we examined whether p38 MAPK signalling is associated with the development of human and experimental diabetic nephropathy.
Immunostaining identified phosphorylated (active) p38 MAPK in human biopsies with no abnormality ( n=6) and with Type 2 diabetic nephropathy ( n=12). Changes in kidney levels of phosphorylated p38 were assessed by immunostaining and western blotting in mice with streptozotocin-induced Type 1 diabetes that had been killed after 0.5, 2, 3, 4 and 8 months, and in Type 2 diabetic db/db mice at 2, 4, 6 and 8 months of age.
Phosphorylated p38 was detected in some intrinsic cells in normal human kidney, including podocytes, cortical tubules and occasional interstitial cells. Greater numbers of these phosphorylated p38+ cells were observed in diabetic patients, and phosphorylated p38 was identified in accumulating interstitial macrophages and myofibroblasts. A similar pattern of p38 activation was observed in both mouse models of diabetes. In mice, kidney levels of phosphorylated p38 increased (2-6 fold) following the onset of Type 1 and Type 2 diabetes. In both mouse models, interstitial phosphorylated p38+ cells were associated with hyperglycaemia, increased HbA(1)c levels and albuminuria. Further assessment of streptozotocin-induced diabetic nephropathy showed that interstitial phosphorylated p38+ cells correlated with interstitial fibrosis (myofibroblasts, collagen).
CONCLUSIONS/INTERPRETATION: Increased p38 MAPK signalling is a feature of human and experimental diabetic nephropathy. Time course studies in mouse models suggest that phosphorylation of p38 plays a pathological role, particularly in the development of interstitial fibrosis.
目的/假设:炎症和纤维化是部分受p38丝裂原活化蛋白激酶(MAPK)信号通路细胞信号传导调节的病理机制。糖尿病环境中的因素,如高血糖和晚期糖基化终产物,可诱导肾细胞中该信号通路的激活。因此,我们研究了p38 MAPK信号传导是否与人类和实验性糖尿病肾病的发生发展有关。
免疫染色法在无异常的人类活检组织(n = 6)和2型糖尿病肾病患者活检组织(n = 12)中鉴定磷酸化(活性)p38 MAPK。通过免疫染色和蛋白质印迹法评估链脲佐菌素诱导的1型糖尿病小鼠在0.5、2、3、4和8个月处死时肾脏中磷酸化p38水平的变化,以及2、4、6和8月龄2型糖尿病db/db小鼠肾脏中磷酸化p38水平的变化。
在正常人类肾脏的一些固有细胞中检测到磷酸化p38,包括足细胞、皮质肾小管和偶尔的间质细胞。糖尿病患者中观察到更多的这些磷酸化p38+细胞,并且在积聚的间质巨噬细胞和成肌纤维细胞中鉴定到磷酸化p38。在两种糖尿病小鼠模型中均观察到类似的p38激活模式。在小鼠中,1型和2型糖尿病发病后肾脏中磷酸化p38水平升高(2至6倍)。在两种小鼠模型中,间质磷酸化p38+细胞均与高血糖、糖化血红蛋白水平升高和蛋白尿相关。对链脲佐菌素诱导的糖尿病肾病的进一步评估表明,间质磷酸化p38+细胞与间质纤维化(成肌纤维细胞、胶原蛋白)相关。
结论/解读:p38 MAPK信号传导增加是人类和实验性糖尿病肾病的一个特征。小鼠模型中的时间进程研究表明,p38的磷酸化发挥病理作用,尤其是在间质纤维化的发生发展中。